250 related articles for article (PubMed ID: 28168355)
21. High resolution metabolomics to discriminate compounds in serum of male lung cancer patients in South Korea.
Pamungkas AD; Park C; Lee S; Jee SH; Park YH
Respir Res; 2016 Aug; 17(1):100. PubMed ID: 27506545
[TBL] [Abstract][Full Text] [Related]
22. Simultaneous quantification of serum monounsaturated and polyunsaturated phosphatidylcholines as potential biomarkers for diagnosing non-small cell lung cancer.
Chen Y; Ma Z; Zhong J; Li L; Min L; Xu L; Li H; Zhang J; Wu W; Dai L
Sci Rep; 2018 May; 8(1):7137. PubMed ID: 29740076
[TBL] [Abstract][Full Text] [Related]
23. Detection and verification of coexisting diagnostic markers in plasma and serum of patients with non-small-cell lung cancer.
Yu M; Sun R; Zhao Y; Shao F; Zhu W; Aa J
Future Oncol; 2021 Nov; 17(32):4355-4369. PubMed ID: 34674559
[TBL] [Abstract][Full Text] [Related]
24. Serum metabolomic profiling facilitates the non-invasive identification of metabolic biomarkers associated with the onset and progression of non-small cell lung cancer.
Puchades-Carrasco L; Jantus-Lewintre E; Pérez-Rambla C; García-García F; Lucas R; Calabuig S; Blasco A; Dopazo J; Camps C; Pineda-Lucena A
Oncotarget; 2016 Mar; 7(11):12904-16. PubMed ID: 26883203
[TBL] [Abstract][Full Text] [Related]
25. Identification of serum miRNAs by nano-quantum dots microarray as diagnostic biomarkers for early detection of non-small cell lung cancer.
Fan L; Qi H; Teng J; Su B; Chen H; Wang C; Xia Q
Tumour Biol; 2016 Jun; 37(6):7777-84. PubMed ID: 26695145
[TBL] [Abstract][Full Text] [Related]
26. Metabolomic profiling of human serum in lung cancer patients using liquid chromatography/hybrid quadrupole time-of-flight mass spectrometry and gas chromatography/mass spectrometry.
Chen Y; Ma Z; Li A; Li H; Wang B; Zhong J; Min L; Dai L
J Cancer Res Clin Oncol; 2015 Apr; 141(4):705-18. PubMed ID: 25293627
[TBL] [Abstract][Full Text] [Related]
27. Serum lipidome screening in patients with stage I non-small cell lung cancer.
Klupczynska A; Plewa S; Kasprzyk M; Dyszkiewicz W; Kokot ZJ; Matysiak J
Clin Exp Med; 2019 Nov; 19(4):505-513. PubMed ID: 31264112
[TBL] [Abstract][Full Text] [Related]
28. miR-1254 and miR-574-5p: serum-based microRNA biomarkers for early-stage non-small cell lung cancer.
Foss KM; Sima C; Ugolini D; Neri M; Allen KE; Weiss GJ
J Thorac Oncol; 2011 Mar; 6(3):482-8. PubMed ID: 21258252
[TBL] [Abstract][Full Text] [Related]
29. Improving global feature detectabilities through scan range splitting for untargeted metabolomics by high-performance liquid chromatography-Orbitrap mass spectrometry.
Ranninger C; Schmidt LE; Rurik M; Limonciel A; Jennings P; Kohlbacher O; Huber CG
Anal Chim Acta; 2016 Aug; 930():13-22. PubMed ID: 27265900
[TBL] [Abstract][Full Text] [Related]
30. Diagnostic and prognostic value of serum thioredoxin and DJ-1 in non-small cell lung carcinoma patients.
Fan J; Yu H; Lv Y; Yin L
Tumour Biol; 2016 Feb; 37(2):1949-58. PubMed ID: 26334622
[TBL] [Abstract][Full Text] [Related]
31. Diagnostic Value of Serum miR-182, miR-183, miR-210, and miR-126 Levels in Patients with Early-Stage Non-Small Cell Lung Cancer.
Zhu W; Zhou K; Zha Y; Chen D; He J; Ma H; Liu X; Le H; Zhang Y
PLoS One; 2016; 11(4):e0153046. PubMed ID: 27093275
[TBL] [Abstract][Full Text] [Related]
32. Urinary metabolomic study of non-small cell lung carcinoma based on ultra high performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry.
Wu Q; Wang Y; Gu X; Zhou J; Zhang H; Lv W; Chen Z; Yan C
J Sep Sci; 2014 Jul; 37(14):1728-35. PubMed ID: 24771673
[TBL] [Abstract][Full Text] [Related]
33. Large-scale targeted metabolomics method for metabolite profiling of human samples.
Cao G; Song Z; Hong Y; Yang Z; Song Y; Chen Z; Chen Z; Cai Z
Anal Chim Acta; 2020 Aug; 1125():144-151. PubMed ID: 32674760
[TBL] [Abstract][Full Text] [Related]
34. Serum reactive oxygen species modulator 1 (Romo1) as a potential diagnostic biomarker for non-small cell lung cancer.
Lee SH; Lee JS; Lee EJ; Min KH; Hur GY; Lee SH; Lee SY; Kim JH; Lee SY; Shin C; Shim JJ; Kang KH; In KH
Lung Cancer; 2014 Aug; 85(2):175-81. PubMed ID: 24951318
[TBL] [Abstract][Full Text] [Related]
35. Serum proton NMR metabolomics analysis of human lung cancer following microwave ablation.
Hu JM; Sun HT
Radiat Oncol; 2018 Mar; 13(1):40. PubMed ID: 29530051
[TBL] [Abstract][Full Text] [Related]
36. Mass spectrometric identification, characterization and validation of the haptoglobin β-chain protein as a lung cancer serum biomarker.
Ayyub A; Saleem M; Musharraf SG; Naz M; Tariq A; Hashmi N
Mol Med Rep; 2015 Sep; 12(3):3755-3762. PubMed ID: 26005016
[TBL] [Abstract][Full Text] [Related]
37. Diagnostic and Prognostic Value of Serum Angiopoietin-Like Protein 2 in Patients with Non-Small Cell Lung Cancer.
Chen Y; Jiang H; Zhu L; Wang P; Liu S; Xiao X; Yu H; Dong W
Clin Lab; 2017 Jan; 63(1):59-65. PubMed ID: 28164488
[TBL] [Abstract][Full Text] [Related]
38. Carbonic anhydrase 1 is a promising biomarker for early detection of non-small cell lung cancer.
Wang DB; Lu XK; Zhang X; Li ZG; Li CX
Tumour Biol; 2016 Jan; 37(1):553-9. PubMed ID: 26232327
[TBL] [Abstract][Full Text] [Related]
39. Metabolomic, transcriptomic and genetic integrative analysis reveals important roles of adenosine diphosphate in haemostasis and platelet activation in non-small-cell lung cancer.
Hoang LT; Domingo-Sabugo C; Starren ES; Willis-Owen SAG; Morris-Rosendahl DJ; Nicholson AG; Cookson WOCM; Moffatt MF
Mol Oncol; 2019 Nov; 13(11):2406-2421. PubMed ID: 31461552
[TBL] [Abstract][Full Text] [Related]
40. Quantitative analysis of amino acids and acylcarnitines combined with untargeted metabolomics using ultra-high performance liquid chromatography and quadrupole time-of-flight mass spectrometry.
Roy C; Tremblay PY; Bienvenu JF; Ayotte P
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Aug; 1027():40-9. PubMed ID: 27240302
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
